Novel surgical glue moves closer to FDA application

09/16/2011 | Pittsburgh Post-Gazette · American City Business Journals

European Union officials approved the sale of a surgical glue that the manufacturer says reduces fluid accumulation and reduces the need for drainage of surgical wounds. TissuGlu is dispensed through a handheld applicator and adheres the skin flap to tissue, closing spaces where fluid can build up. Manufacturer Cohera Medical plans to file for FDA approval by the end of the year and begin clinical trials early next year.

View Full Article in:

Pittsburgh Post-Gazette · American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Legal
Merck Sharp & Dohme
Whitehouse Station, NJ
Vice President, Global Quality Collaboration, Standards & Harmonization
Mylan
Canonsburg, PA
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Director, Marketing
The Food and Drug Law Institute
Washington, DC
Behavioral Health Medical Director
Network Health
Medford, MA